Zylox-Tonbridge to Acquire Germany's Optimed in a Move to Expand Global Vascular Devices Footprint
Multi-step acquisition of Optimed strengthens Zylox-Tonbridge’s European footprint, R&D capabilities and global commercialisation of minimally invasive vascular solutions.
Hans-Henning Von Oertzen | 17/01/2026 | By News Bureau | 318
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy